Showing results (1761-1770 of 3,024) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|April 28, 2010
The cardiovascular and cardiac actions of ecstasy and its metabolitesS K Shenouda, F Carvalho, K J VarnerCurrent Pharmaceutical Biotechnology|April 28, 2010
Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): human and animal dataEls A De Letter, Christophe P Stove, Willy E Lambert, et al.Current Pharmaceutical Biotechnology|May 28, 2010
Diffusion-weighted MRI for assessment of early cancer treatment responseStefanie Galbán, Jean-Christophe Brisset, Alnawaz Rehemtulla, et al.Current Pharmaceutical Biotechnology|November 2, 2006
New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaShinya Kimura, Eishi Ashihara, Taira MaekawaCurrent Pharmaceutical Biotechnology|June 23, 2007
Using the neurosphere assay to quantify neural stem cells in vivoGregory P Marshall, Brent A Reynolds, Eric D LaywellCurrent Pharmaceutical Biotechnology|June 23, 2007
Adult neurogenesis in mesial temporal lobe epilepsy: a review of recent animal and human studiesY W J Liu, E W Mee, P Bergin, et al.Current Pharmaceutical Biotechnology|December 16, 2006
Arsenic trioxide in hematological malignancies: the new discovery of an ancient drugA Bonati, V Rizzoli, P LunghiCurrent Pharmaceutical Biotechnology|December 16, 2006
Targeting signaling pathways in multiple myelomaCavallo Federica, Palumbo Antonio, Tricot Guido, et al.Current Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido TricotCurrent Pharmaceutical Biotechnology|December 16, 2006
Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?Ruth Lupu, Javier A MenendezPageof 303